{"Clinical Trial ID": "NCT03167359", "Intervention": ["INTERVENTION 1:", "Participants with breast cancer in stage 0-III", "Women with stage 0-III breast cancer who are treated with breast conservation surgery or mastectomy and clear margins will receive 15 doses of radiation over three weeks.", "Hypofractionated Simultaneous Integrated Boost Radiotherapy: Participants will receive radiotherapy treatments on the entire chest or chest wall at a dose of 2.66 Gy per day x 15 fractions at the same time as stimulation treatment. Stimulation treatment will be given on the same days as treatment for the whole breast."], "Eligibility": ["Incorporation criteria:", "Participants must have one or more of the following characteristics and be eligible for breast or chest wall therapy with or without regional nodal radiation therapy:", "Previous chemotherapy for breast cancer", "More than 25 cm of breast separation (the greatest distance on an axial slice of the CT simulation analysis projected between the points of entry and exit of the radiation beam on the body)", "Non-Caucasian race", "Less than 50 years or equal to 50 years", "\u2022 Demanding regional nodal irradiation without evidence of N3 disease", "- Exclusion criteria:", "\u266a Men will be excluded \u266a", "Women who are pregnant or breast-feeding may not participate in this study."], "Results": ["Performance measures:", "Number of participants by degree of skin toxicity (0, 1, 2, 3, 4)", "Grade 0: none Grade 1: Slim or localized; topical intervention indicated Grade 2: Intense or generalized; intermittent; skin changes from scratching (e.g., oedema, papulation, excoriations, lichenification, ozing/crusts); limitation of instrumental ALDs Grade 3-4: Serious or life-threatening.", "Duration of study (up to 18 months)", "Results 1:", "Title of the arm/group: Breast cancer participants in stage 0-III", "Description of the arm/group: Women with breast cancer in stage 0-III, treated with breast conservation surgery or mastectomy and clear margins, will receive 15 doses of radiation over three weeks.", "Hypofractionated Simultaneous Integrated Boost Radiotherapy: Participants will receive radiotherapy treatments on the entire chest or chest wall at a dose of 2.66 Gy per day x 15 fractions at the same time as stimulation treatment. Stimulation treatment will be given on the same days as treatment for the whole breast.", "Total number of participants analysed: 71", "Type of measure: Number of participants", "Unit of measure: Participants Level 0: 60 84.5 %", "Grade 1 : 11 15.5%", "Level 2: 0 0.0%", "Level 3: 0 0.0%", "Grade 4: 0 0.0%"], "Adverse Events": ["Undesirable Events 1:", "Total: 3/74 (4.05 per cent)", "*3/74 (4.05 per cent)"]}